Food and Drug Administration
Center for Biologics Evaluation and Research
Recommended Reading
for the
Oncologic Drugs Advisory Committee Meeting
December 5, 2001
The Development of Diagnostic Immunohistochemistry (IHC) and Fluorescence in situ Hybridization (FISH) Assays Intended to Identify Patients Who Might Benefit from Treatment with a Particular Therapeutic Product
Focus on Characterization and Interpretation of Assay Results
Additional References:
O’Leary, Timothy J. Standardization in Immunohistochemistry. Applied Immunohistochemistry and Molecular Morphology 9(1): 3-8, 2001.
Test and Technology Transfer Committee: Watson, Michael S., Buchanan, Philip D., Cohen Maimon M., DeWald, Gordon W., Ledbetter, David H., Goldberg, James D., Wapner, Ronald J. Technical and clinical assessment of fluorescence in situ hybridization: An ACMG/ASHG position statement. I. Technical considerations. Genetics in Medicine: 2(6), 2000.
Barker, Peter E., Watson, Michael S., Ticehurst, John R., Colbert, Jennifer C., O’Connell, Catherine D. NIST Physical Standards for DNA-Based Medical Testing. Journal of Clinical Laboratory Analysis, vol 16 (1)- in press, pagination to be determined